SphingoTec
PrivateLast Round
Series C
Aug 8, 2024
Total Funding Raised
$28.55M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
SphingoTec operates in Healthcare & Life Sciences and is based in Hennigsdorf. Its latest recorded funding round was a Series C round in August 2024.
SphingoTec is a diagnostics company that develops and markets innovative in vitro diagnostic (IVD) tests for novel and proprietary biomarkers for the diagnosis, prediction and monitoring of acute medical conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SphingoTec Comparables
Compare SphingoTec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immunexpress | 78% | |
| BioPorto A/S | 77% | |
| Inflammatix | 72% |
For institutional investors. Book with your work email.
SphingoTec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 8, 2024 | ||||
| VC Round | Feb 21, 2024 | ||||
| Growth Equity | Oct 8, 2018 |
For institutional investors. Book with your work email.
SphingoTec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Think.Health | Series C |
| HBM Healthcare Investments | Series C, Growth Equity |
| NRW.Bank | Series C |
| Brandenburg Kapital | Series C |
| Wellington Partners | Series C, Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 29, 2026
Grew 18% QoQ, from 17 to 20 employees.
- Jan 20, 2026
Monthly visitors grew 263% MoM, reaching 2K.
For institutional investors. Book with your work email.
SphingoTec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SphingoTec's valuation, stock price, and market status.
Is SphingoTec a public or private company?
SphingoTec is a private company.
What is the current stock price of SphingoTec?
SphingoTec is a private company, so its shares have no public market price. Caplight tracks SphingoTec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SphingoTec worth (valuation)?
Valuation information for SphingoTec is not publicly available.
Can I buy SphingoTec stock?
SphingoTec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SphingoTec's last funding round?
SphingoTec's most recent funding round was Series C on August 8, 2024.
Who are the main investors in SphingoTec?
Key investors in SphingoTec include Think.Health, HBM Healthcare Investments, Wellington Partners.
Will SphingoTec IPO soon?
No public IPO plans have been announced for SphingoTec.
How can I track SphingoTec secondary market activity?
Caplight tracks bids, offers, and trades in SphingoTec's shares on secondary markets.